Ming Xian - MEDIFAST INC Independent Director
| MED Stock | USD 13.94 0.07 0.50% |
Director
Mr. Ming Xian is Independent Director of the company. Mr. Xian is Project Director of Sinochem International Pte, Ltd. and served as Chairman of Sinochem from August 2008 to August 2010. Mr. Xian also served as Chief Strategy Officer of DSM Sinochem Pharmaceuticals from September 2011 to January 2017. He also served as Chairman of GMG Global from August 2008 to August 2010 and its Chief Executive Officer from August 2010 to August 2011 since 2018.
| Age | 56 |
| Tenure | 7 years |
| Address | 100 International Drive, Baltimore, MD, United States, 21202 |
| Phone | 410 581 8042 |
| Web | https://medifastinc.com |
Ming Xian Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ming Xian against MEDIFAST INC stock is an integral part of due diligence when investing in MEDIFAST INC. Ming Xian insider activity provides valuable insight into whether MEDIFAST INC is net buyers or sellers over its current business cycle. Note, MEDIFAST INC insiders must abide by specific rules, including filing SEC forms every time they buy or sell MEDIFAST INC'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ming Xian over six months ago Acquisition by Ming Xian of 10149 shares of MEDIFAST INC subject to Rule 16b-3 |
MEDIFAST INC Management Efficiency
The company has Return on Asset of 0.0324 % which means that on every $100 spent on assets, it made $0.0324 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0102 %, implying that it generated $0.0102 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. As of March 16, 2025, Return On Tangible Assets is expected to decline to 0.01. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 10.2 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Lawrence Alleva | Bright Horizons Family | 70 | |
| Matthew Winter | HR Block | 63 | |
| Roger Brown | Bright Horizons Family | 62 | |
| Jeremy Weaver | Carriage Services | N/A | |
| Cathy Minehan | Bright Horizons Family | 73 | |
| Patrick Gunning | Rollins | 61 | |
| Anuradha Gupta | HR Block | 51 | |
| Jerry Nix | Rollins | 75 | |
| Barry Fingerhut | Carriage Services | 75 | |
| Sean Cohan | HR Block | 45 | |
| Bryan Leibman | Carriage Services | 52 | |
| Julie Atkinson | Bright Horizons Family | 46 | |
| Deepak Mulchandani | Interactive Strength Common | 53 | |
| Christianna Wood | HR Block | 61 | |
| Sara Tucker | Service International | 65 | |
| Richard Johnson | HR Block | 62 | |
| David Lewis | HR Block | 75 | |
| Bruce Rohde | HR Block | 71 | |
| Harry Cynkus | Rollins | 70 | |
| Susan Bell | Rollins | 58 | |
| Bill Dismuke | Rollins | 82 | |
Management Performance
| Return On Equity | 0.0102 | ||||
| Return On Asset | 0.0324 |
MEDIFAST INC Leadership Team
Elected by the shareholders, the MEDIFAST INC's board of directors comprises two types of representatives: MEDIFAST INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDIFAST. The board's role is to monitor MEDIFAST INC's management team and ensure that shareholders' interests are well served. MEDIFAST INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDIFAST INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MacDonald, Chairman, CEO and Chairman of Executive Committee | ||
| Jonathan Mackenzie, Chief Accounting Officer | ||
| Ming Xian, Independent Director | ||
| Anthony Tyree, Chief Marketing Officer | ||
| Michael Hoer, Independent Director | ||
| Daniel Chard, Executive Chairman of the Board, Chief Executive Officer | ||
| James CPA, Chief Officer | ||
| Jeffrey Brown, Lead Independent Director | ||
| William Baker, Executive Vice President Information Technology | ||
| Stephen Johnson, Chief Accounting Officer, Vice President - Finance | ||
| Andrea Thomas, Independent Director | ||
| Lauren Walker, Executive Vice President - Supply Chain Operations | ||
| Jason Esq, General VP | ||
| Jason Groves, Executive Vice President, General Counsel, Corporate Secretary | ||
| Steven Zenker, Vice Relations | ||
| Joseph Kelleman, Interim Chief Financial Officer, Vice President - Finance | ||
| Scott Schlackman, Independent Director | ||
| James Maloney, Chief Financial Officer, Interim Principal Accounting Officer | ||
| Kevin Byrnes, Independent Director | ||
| Carl Sassano, Independent Director | ||
| Constance Hallquist, Independent Director | ||
| Nicholas Johnson, Executive Vice President - Coach Success, Market President of OPTAVIA USA | ||
| Claudia Greninger, Executive Vice President - Human Resources |
MEDIFAST Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDIFAST INC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0102 | ||||
| Return On Asset | 0.0324 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 6.25 M | ||||
| Shares Outstanding | 10.94 M | ||||
| Shares Owned By Insiders | 2.54 % | ||||
| Shares Owned By Institutions | 83.35 % | ||||
| Number Of Shares Shorted | 1.39 M | ||||
| Price To Earning | 13.99 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth (0.38) | Return On Assets |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.